INSMED Inc
INSM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001104506
In the last 90 days, INSMED Inc insiders filed 0 open-market purchases and 7 sales; 667 institutions reported holding it in 13F filings for Q2 2026, worth $23.8B in total; superinvestors Maverick Capital and Duquesne Family Office hold it.
13F holders, Q2 2024
Institutional positions in INSMED Inc as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 378
- +93 vs. Q1 2024
- Shares held
- 175.3M
- +25.4M (+17.0%) vs. Q1 2024
- Total value
- $11.7B
- +$7.68B (+189.0%) vs. Q1 2024
- New holders
- 130
- 132 more added
- Sold out
- 37
- 100 more reduced
3 institutions that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting INSM on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 667 | $23.8B |
| Q1 2026 | 675 | $35.7B |
| Q4 2025 | 678 | $37.8B |
| Q3 2025 | 566 | $30.3B |
| Q2 2025 | 516 | $21.2B |
| Q1 2025 | 442 | $15.3B |
| Q4 2024 | 439 | $13.3B |
| Q3 2024 | 414 | $13.7B |
| Q2 2024 | 378 | $11.7B |
| Q1 2024 | 288 | $4.07B |
| Q4 2023 | 271 | $4.64B |
| Q3 2023 | 252 | $3.72B |
| Q2 2023 | 223 | $3.09B |
| Q1 2023 | 230 | $2.48B |
| Q4 2022 | 225 | $2.87B |
| Q3 2022 | 238 | $2.74B |
| Q2 2022 | 214 | $2.55B |
| Q1 2022 | 224 | $2.97B |
| Q4 2021 | 214 | $3.36B |
| Q3 2021 | 193 | $3.40B |
| Q2 2021 | 203 | $3.46B |
| Q1 2021 | 199 | $3.63B |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding INSMED Inc; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Fox Run Management, L.L.C. | 0 | $0 | 0.00% | −16,416−100.0% | Sold out |
| EP Wealth Advisors, LLC | 0 | $0 | 0.00% | −16,303−100.0% | Sold out |
| Worth Venture Partners, LLC | 0 | $0 | 0.00% | −15,400−100.0% | Sold out |
| Point72 (DIFC) Ltd | 0 | $0 | 0.00% | −14,298−100.0% | Sold out |
| Dark Forest Capital Management LP | 0 | $0 | 0.00% | −10,563−100.0% | Sold out |
| Atom Investors LP | 0 | $0 | 0.00% | −9,324−100.0% | Sold out |
| Teza Capital Management LLC | 0 | $0 | 0.00% | −8,984−100.0% | Sold out |
| Metropolitan Life Insurance Co | 0 | $0 | 0.00% | −7,265−100.0% | Sold out |
| Lazard Asset Management LLC | 0 | $0 | 0.00% | −3,136−100.0% | Sold out |
| Headlands Technologies LLC | 0 | $0 | 0.00% | −2,168−100.0% | Sold out |
| Catalyst Funds Management Pty Ltd | 0 | $0 | 0.00% | −1,600−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −592−100.0% | Sold out |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 0 | $0 | 0.00% | −138−100.0% | Sold out |
| Truvestments Capital LLC | 0 | $0 | 0.00% | −84−100.0% | Sold out |
| CIBC Private Wealth Group, LLC | 0 | $0 | 0.00% | −15−100.0% | Sold out |
| Credit Suisse AG | – | – | – | – | Not filed |
| Shell Asset Management Co | – | – | – | – | Not filed |
| Cipher Capital LP | – | – | – | – | Not filed |